✦ LIBER ✦

Treatment of Focal Dystonia

✍ Scribed by Batla, Amit; Stamelou, Maria; Bhatia, Kailash P.

Book ID: 111654589
Publisher: Springer
Year: 2012
Tongue: English
Weight: 223 KB
Volume: 14
Category: Article
ISSN: 1092-8480
DOI: 10.1007/s11940-012-0169-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of focal dystonias with botuli

Treatment of focal dystonias with botulinum neurotoxin

✍ Mark Hallett; Reiner Benecke; Andrew Blitzer; Cynthia L. Comella 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Focal limb dystonia

✍ C. Pont-Sunyer; M. J. Martí; E. Tolosa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Focal hand dystonia

✍ Hallett Mark 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Motor training as treatment in focal han

Motor training as treatment in focal hand dystonia

✍ Kirsten E. Zeuner; Holly A. Shill; Young H. Sohn; Fiona M. Molloy; Bonnie C. Tho 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

## Abstract Focal hand dystonia may arise as a result of aberrant plasticity from excessive repetitive use. Improvement might be possible with appropriate motor training. Focusing on trying to decrease abnormal overflow of movement to fingers not involved in a task, we developed a motor training pr

Anticholinergic-induced chorea in the tr

Anticholinergic-induced chorea in the treatment of focal dystonia

✍ M. Nomoto; P. D. Thompson; M. P. Sheehy; N. P. Quinn; C. D. Marsden 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB

The occurrence of chorea, induced by trihexyphenidyl (benzhexol hydrochloride) during the treatment of five adult patients who had focal or segmental dystonia, is described. The dose at which chorea appeared ranged from 15 to 60 mg/day (mean 31.7 mglday). All but one patient had developed common adv

Botulinum toxin treatment of occupationa

Botulinum toxin treatment of occupational and focal hand dystonia

✍ Barbara Illowsky Karp 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB

Botulinum toxin is now the first-line therapy for writer's cramp and other occupational dystonias, with wellestablished efficacy and safety. Future studies will allow us to understand better the physiological effects of injection and to refine and enhance our treatment of focal hand dystonia.